Novo Nordisk A/S (NVO)
Novo Nordisk A/S Cash & Cash Equivalents
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $629.4M | $523.4M | $577.8M | $941.9M | $1,647.4M | $2,168.8M | $2,151.0M | $2,331.7M | $2,036.8M | $1,976.1M | $2,337.9M | $2,462.3M | $2,642.8M | $3,033.3M | $2,402.0M | $2,316.6M | $2,089.6M | $1,638.4M | $1,815.7M | $2,130.3M |
Novo Nordisk A/S (NVO) Cash & Cash Equivalents comparison analysis
NVO key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Novo Nordisk A/S's Cash & Cash Equivalents?
As of today, Novo Nordisk A/S's last 12-month Cash & Cash Equivalents is $8,508.8M, based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is Novo Nordisk A/S's Cash & Cash Equivalents growth rate?
Over the last year, Novo Nordisk A/S's Cash & Cash Equivalents growth was 99.6%. The average annual Cash & Cash Equivalents growth rates for Novo Nordisk A/S have been 111.8% over the past three years, 25.5% over the past five years.
3) Is Novo Nordisk A/S's Cash & Cash Equivalents growth rate Good?
Over the last year, Novo Nordisk A/S's Cash & Cash Equivalents growth was 99.6%, which is higher than industry growth of (0.2%). It indicates that Novo Nordisk A/S's Cash & Cash Equivalents growth is Good.